Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Disease Foundation Marks Tenth Year of People with Parkinson’s Advisory Council

Patient Advisors Drive PDF Mission to Solve, Treat and End Parkinson’s

The Parkinson’s Disease Foundation® (PDF®) is pleased to mark the tenth year of its People with Parkinson’s Advisory Council and welcome five new members. Created in 2006, the council is made up of people living with Parkinson’s and care partners who drive PDF’s goals of ending the disease and improving the lives of those affected by it.

“As the PDF People with Parkinson’s Advisory Council marks a new decade, we renew our commitment to representing the community’s urgency for better treatments and a cure, and to guiding PDF toward the programs that best meet community needs,” said Daniel Novak, Ph.D., of Fort Worth, TX, who was recently elected Chair of the advisory council. “As a pioneer in patient engagement, PDF has long understood that an informed and empowered patient community is instrumental to ending this disease.”

Advisory council members guide PDF’s mission and priorities; identify and solve unmet needs; provide input on programs; and serve as liaisons to the community. The advisory council has helped to prompt some of PDF’s more important initiatives, including its Community Choice Research Awards, which seek feedback from the patient community on research; its patient education materials, including the popular Parkinson’s Disease Resource List and bi-monthly webinars; and its innovative patient advocacy programs, including the newly launched Women and PD Initiative and the PD SELF program.

The advisory council’s newest members represent a wide range of communities, professions and personal experiences. They include the following individuals:

Mary Bendelow, Ph.D., of Conifer, CO: a retired communications consultant who currently serves as a tour director for US and Canadian national parks.

Andrée Jannette of West Chester, PA: a freelance writer and photographer with more than 20 years of experience working in strategic traditional and digital communications.

Rebecca Miller, Ph.D., of New Haven, CT: a clinical psychologist, Director of Peer Support and Family Initiatives at Connecticut Mental Health Center and Assistant Professor at Yale School of Medicine, Department of Psychiatry.

Leslie Peters of Colorado Springs, CO: a health care coordinator, care partner to her husband who lives with Parkinson’s and former care partner to her late mother-in-law who lived with the disease.

Paul Rohrlich, Ph.D., of Falls Church, VA: a retired foreign service officer with more than 25 years of experience working as an economic, environment and science officer with the US Department of State.

“Over the past decade, PDF has benefitted from the guidance and wisdom of more than 40 members of this advisory council, who have helped us to better understand and address community needs and who have worked tirelessly to improve the lives of people with Parkinson’s,” said Robin Anthony Elliott, PDF President. “For PDF, these accomplishments are proof that engaging the patient community in our work is not only the right thing to do; it is also effective.”

About Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US. Although promising research is being conducted, there is currently no cure for Parkinson's disease.

Tuesday, May 24, 2016
The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Parkinson’s Foundation Appoints Jena E. Abernathy to Board of Directors
Tuesday, February 27, 2018

MIAMI – February 27, 2018 –  The Parkinson’s Foundation today announced the election of Jena E. Abernathy to its board of directors.

Parkinson’s Foundation Moving Day Walks Fund Local Parkinson’s Programs in Seven Cities for Spring 2018
Friday, February 16, 2018

NEW YORK & MIAMI, FEBRUARY 16, 2018 — The Parkinson’s Foundation is proud to announce that Moving Day, A Walk for Parkinson’s, has funded more than $17 million in mission services to make life better for people living with Parkinson’s disease (PD).

Terranova’s Stephen Bittel Donates $450,000 to Parkinson’s Foundation to Support Expansion of Centers of Excellence Network
Thursday, February 1, 2018

MIAMI – February 1, 2018 – The Parkinson’s Foundation today announced that Stephen Bittel, chairman and founder of Terranova, has made a $450,000 donation to support the expansion of the foundation’s Centers o

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.